| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8217671 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 7 Pages |
Abstract
This comparative effectiveness analysis of SBRT dose for patients with stage I non-small-cell lung cancer suggests that higher doses (>150Â Gy BED) are associated with a significant survival benefit in patients with T2 tumors.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Matthew MD, Renuka MD, Ralph R. MD, David J. MD, MPH,